{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-251689","form_type":"8-K","ticker":"WW","cik":"0000105319","company_name":"WW INTERNATIONAL, INC.","filed_at":"2024-11-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:07.509135+00:00","generated_at":"2026-05-30T04:17:24.981586+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"WW International Q3 revenue $192.9M, operating loss $39M; subscribers down 8.8%","bullets":["Revenue $192.9M (-10.2% YoY); subscription revenue $191.2M (-6.0%).","GAAP operating loss $39.0M vs income $30.6M; includes $57M franchise rights impairment.","Adjusted operating income $35.7M (-2.5%); adjusted EPS $0.24 (-60.6%).","End-of-period subscribers 3.7M (-8.8%); clinical subscribers up 71.5% to ~0.1M.","Interim CEO Tara Comonte acknowledges 'significant work' to unify solutions and restore growth."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-251689","json":"https://secwatch.observer/filing/0001193125-24-251689.json","markdown":"https://secwatch.observer/filing/0001193125-24-251689.md","text":"https://secwatch.observer/filing/0001193125-24-251689.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/105319/000119312524251689/0001193125-24-251689-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/105319/000119312524251689/d812623d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T04:17:24.981586+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}